Progestin-only products may be a "safer alternative" for this patient population, according to a new analysis. 

Erin D. Michos, MD, co-editor in chief of the American Journal of Preventive Cardiology, discusses gender differences in heart disease presentations.

CBD is generally viewed as a safe, well-tolerated treatment option, but there is still limited research on how it interacts with other medications commonly prescribed by cardiologists. 

These findings, researchers wrote, suggest that artificial sweeteners "should not be considered a healthy and safe alternative to sugar."

“Religiosity and spirituality may serve as buffers to stress and have therapeutic effects," according to one Mayo Clinic cardiologist involved in the study. 

New research, published in JAMA Cardiology, challenges the common belief that AFib is more likely to develop among men than women. The key problem, it seems, is that prior research teams did not understand the significance of certain risk factors.

The USPSTF recommends statin use for high-risk patients between the ages of 40 to 75 to help prevent a first heart attack or stroke. Other patients in that same age group may also benefit, the group noted, but physician input is needed. 

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.